Dual-Chamber Pacers Help Reduce Thromboembolic Event Risk - AHA Study
This article was originally published in The Gray Sheet
Executive Summary
Use of dual-chamber in lieu of single-chamber pacemakers for ventricular pacing can lower platelet activation in the heart and reduce the risk of thromboembolic events, William Toff, MD, University of Leicester (UK) told attendees of the American Heart Association's scientific sessions Nov. 10 in Atlanta.
You may also be interested in...
Dual-Chamber v. Single-Chamber Pacemaker Use Debated At NASPE
Anticipated results from two early stage studies - the Mode Selection Trial (MOST) and the PAGE trial in the UK - will further support evidence to date that use of dual-chamber pacemakers is unnecessary in the majority of patients, according to Ronald Vliestra, MD, Watson Clinic, Lakeland, Florida.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.